Edition:
United States

Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

30.66USD
13 Jan 2017
Change (% chg)

$0.47 (+1.56%)
Prev Close
$30.19
Open
$30.55
Day's High
$31.02
Day's Low
$30.35
Volume
251,133
Avg. Vol
500,013
52-wk High
$41.91
52-wk Low
$24.47

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.25 December 16 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 3
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 4 115.12 125.00 96.80 --
Quarter Ending Jun-17 4 132.93 146.00 123.20 --
Year Ending Dec-17 6 552.93 610.00 497.30 582.63
Earnings (per share)
Quarter Ending Mar-17 4 0.25 0.34 0.21 --
Quarter Ending Jun-17 4 0.46 0.78 0.23 --
Year Ending Dec-17 4 2.17 2.95 1.52 2.48
LT Growth Rate (%) 1 22.00 22.00 22.00 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 112.30 142.91 30.61 27.26
Quarter Ending Jun-16 111.20 101.49 9.72 8.74
Quarter Ending Mar-16 101.83 111.00 9.17 9.01
Quarter Ending Dec-15 168.07 168.10 0.04 0.02
Quarter Ending Sep-15 151.42 164.94 13.52 8.93
Earnings (per share)
Quarter Ending Sep-16 0.38 0.58 0.20 54.67
Quarter Ending Jun-16 -0.17 -0.18 0.01 -4.35
Quarter Ending Mar-16 -0.07 0.16 0.23 -328.57
Quarter Ending Dec-15 0.70 0.78 0.08 11.43
Quarter Ending Sep-15 0.55 0.83 0.28 51.82

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 115.12 115.12 116.50 111.40 --
Quarter Ending Jun-17 132.93 132.93 133.32 135.87 --
Year Ending Dec-17 552.93 552.93 554.05 559.81 582.63
Earnings (per share)
Quarter Ending Mar-17 0.25 0.25 0.25 0.28 --
Quarter Ending Jun-17 0.46 0.46 0.47 0.40 --
Year Ending Dec-17 2.17 2.17 2.20 1.77 2.48

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 0 0 1
Quarter Ending Jun-17 0 0 0 1
Year Ending Dec-17 0 0 0 1
Earnings
Quarter Ending Mar-17 0 0 1 0
Quarter Ending Jun-17 0 0 0 1
Year Ending Dec-17 0 0 0 1